Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Birsen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Bulletin Du Cancer|March 28, 2025
[ALK rearrangement in non-small cell lung cancer]Gaspard Naulleau, Gary Birsen, Audrey Mansuet-Lupo, et al.
Bulletin Du Cancer|March 28, 2025
[Treatment with peri-operative immunotherapy of resectable PCNBs]Mariona Riudavets, Gary Birsen, Jeremy Slomka, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2024
The tumor immune microenvironment of SCLC is not associated with its molecular subtypesYoan Velut, Basilia Arqué, Marie Wislez, et al.
Translational Lung Cancer Research|July 11, 2026
End-of-life management and causes of death in ALK-positive non-small cell lung cancer in France: a multicentric analysisGaspard Naulleau, Gary Birsen, Pascal Wang, et al.
Plos One|November 7, 2024
Clinical and molecular characteristics associated with high PD-L1 expression in EGFR-mutated lung adenocarcinomaJeremy Slomka, Hugo Berthou, Audrey Mansuet-Lupo, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2024
STK11/LKB1 alterations worsen the poor prognosis of KRAS mutated early-stage non-squamous non-small cell lung carcinoma, results based on the phase 2 IFCT TASTE trialJean Baptiste Oudart, Simon Garinet, Caroline Leger, et al.
Translational Lung Cancer Research|October 21, 2024
Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinomaGary Birsen, Valérie Gounant, Nicolas Girard, et al.
Nature Communications|March 12, 2024
Mitochondrial metabolism sustains CD8<sup>+</sup> T cell migration for an efficient infiltration into solid tumorsLuca Simula, Mattia Fumagalli, Lene Vimeux, et al.
The Lancet. Haematology|October 10, 2024
Maternal and obstetric outcomes in women with pregnancy-associated haematological malignancies: an observational nationwide cohort studyPierre Pinson, Ismael Boussaid, Justine Decroocq, et al.
Joint Bone Spine|July 14, 2025
French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseasesJérôme Avouac, Olivier Fogel, Maxime Beydon, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Bulletin Du Cancer|March 28, 2025
[ALK rearrangement in non-small cell lung cancer]Gaspard Naulleau, Gary Birsen, Audrey Mansuet-Lupo, et al.
Bulletin Du Cancer|March 28, 2025
[Treatment with peri-operative immunotherapy of resectable PCNBs]Mariona Riudavets, Gary Birsen, Jeremy Slomka, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2024
The tumor immune microenvironment of SCLC is not associated with its molecular subtypesYoan Velut, Basilia Arqué, Marie Wislez, et al.
Translational Lung Cancer Research|July 11, 2026
End-of-life management and causes of death in ALK-positive non-small cell lung cancer in France: a multicentric analysisGaspard Naulleau, Gary Birsen, Pascal Wang, et al.
Plos One|November 7, 2024
Clinical and molecular characteristics associated with high PD-L1 expression in EGFR-mutated lung adenocarcinomaJeremy Slomka, Hugo Berthou, Audrey Mansuet-Lupo, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 2024
STK11/LKB1 alterations worsen the poor prognosis of KRAS mutated early-stage non-squamous non-small cell lung carcinoma, results based on the phase 2 IFCT TASTE trialJean Baptiste Oudart, Simon Garinet, Caroline Leger, et al.
Translational Lung Cancer Research|October 21, 2024
Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinomaGary Birsen, Valérie Gounant, Nicolas Girard, et al.
Nature Communications|March 12, 2024
Mitochondrial metabolism sustains CD8<sup>+</sup> T cell migration for an efficient infiltration into solid tumorsLuca Simula, Mattia Fumagalli, Lene Vimeux, et al.
The Lancet. Haematology|October 10, 2024
Maternal and obstetric outcomes in women with pregnancy-associated haematological malignancies: an observational nationwide cohort studyPierre Pinson, Ismael Boussaid, Justine Decroocq, et al.
Joint Bone Spine|July 14, 2025
French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseasesJérôme Avouac, Olivier Fogel, Maxime Beydon, et al.
Pageof 1